The company hasn't reported any concerning news, nor has an analyst announced a downgrade to the stock. Instead, it appears the stock's slide is the result of investors taking profits. As of 11:54 a.m. ET, shares of Zymergen are down 8.5%, rising from their earlier decline of 11.4%.
What's happening with zymergen stock?
1 day ago · After zooming higher yesterday, shares of synthetic-biology specialist Zymergen ( ZY -6.97% ) are moving swiftly in the other direction today. It seems that the usual suspects behind a …
What does zymergen (ZY) do?
Aug 04, 2021 · Zymergen went public at $31 a share in April and traded as high as $48.50, valuing the company at $4.8 billion. The stock sank to $11.07 after hours on Tuesday, leaving its market cap at just over ...
How much has zymergen lost since inception?
Oct 19, 2021 · Zymergen stock sank on Tuesday, falling 12.6% as of 1 p.m. EDT as the stock's lock-up period expired. Notably, Zymergen shares had gained some ground in the past week but with today's drop, shares ...
When does zymergen report financial results for the third quarter?
Find the latest Zymergen Inc. (ZY) stock quote, history, news and other vital information to help you with your stock trading and investing.
Is Zymergen a good stock to buy?
Out of 7 analysts, 0 (0%) are recommending ZY as a Strong Buy, 0 (0%) are recommending ZY as a Buy, 4 (57.14%) are recommending ZY as a Hold, 2 (28.57%) are recommending ZY as a Sell, and 1 (14.29%) are recommending ZY as a Strong Sell.
What's happening with Zymergen?
Zymergen's new management has said that it will need to cut expenses, and industry observers expect massive staff cuts, perhaps 50% or more. In September, Zymergen laid off 120 employees. By June 2021, Zymergen had accumulated total losses of $959 million, according to its latest quarterly report.Oct 13, 2021
Should I sell Zymergen?
There are currently 3 sell ratings and 5 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Zymergen stock.
Why did ZY crash?
ZY Stock: Zymergen Plunges After Calling for No Product Revenue in 2021. Here's Why. The newly minted shares of Zymergen (NASDAQ:ZY) are collapsing in Wednesday's premarket trading after the biotech dumped bad news on investors. ZY stock debuted on April 21 in a Nasdaq initial public offering (IPO).Aug 4, 2021
Is Zymergen a good company?
Is Zymergen a good company to work for? Zymergen has an overall rating of 3.2 out of 5, based on over 173 reviews left anonymously by employees. 54% of employees would recommend working at Zymergen to a friend and 27% have a positive outlook for the business. This rating has been stable over the past 12 months.Apr 11, 2022
Is Zymergen publicly traded?
Zymergen went public at $31 a share in April and traded as high as $48.50, valuing the company at $4.8 billion.Aug 3, 2021
Is Ginkgo Bioworks publicly traded?
Ginkgo Bioworks — a Boston-based company that wants to make biology as easy to program as a computer — began trading on Friday after going public via a SPAC. Why it matters: Ginkgo's multibillion-dollar offering is a milestone in the maturation of synthetic biology from a science to a true industry.Sep 19, 2021
Is Ginkgo Bioworks going public?
Boston-based Ginkgo Bioworks began trading on the New York Stock Exchange on Friday, becoming the latest company to close a SPAC merger and go public. Shares opened at $11.15 apiece under ticker symbol “DNA,” giving the five-time CNBC Disruptor 50 company a market cap of nearly $2.5 billion.Sep 17, 2021
Is Ginkgo Bioworks a publicly traded company?
Last Friday, the Ginkgo team and their families rang the opening bell at the New York Stock Exchange announcing our debut as a publicly traded company under the NYSE ticker DNA, after raising $1.6 billion to accelerate our mission to make biology easier to engineer.Sep 21, 2021
The recently IPO'd synthetic biotechnology start-up ousts its CEO as its only product hits a brick wall
A Fool since 2011, Neha has a keen interest in materials, industrials, and mining sectors. Her favorite pastime: Digging into 10Qs and 10Ks to pull out important information about a company and its operations that an investor may otherwise not know. Other days, you may find her decoding the big moves in stocks that catch her eye.
What happened
Zymergen ( NASDAQ:ZY) stock got slammed this morning and had plunged 76% at 11:25 a.m. EDT, thanks to some jarring updates coming in from the "biofacturing" start-up that went public just this past April via an initial public offering (IPO), whose stock made a stellar debut on the day of listing.
So what
Before I tell you what's exactly happening at Zymergen, some background is important.
Now what
There's not much left to be said here. Whatever little revenue -- to the tune of $5 million or $6 million -- Zymergen expects to generate in the second quarter will come from collaborations and research-and-development agreements.
What is a zymergen?
About Zymergen Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries.
When will Zymergen report financial results?
Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021. EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021.
How much is operating expense for 2021?
Total operating expenses for the first quarter of 2021 were $87.1 million dollars, a 32.8% increase from $65.6 million dollars in the first quarter of 2020.
When is the 2021 Goldman Sachs Virtual Conference?
Zymergen’s management is scheduled to present on Wednesday, June 9th at 5:30 p.m. Eastern Time/2:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.zymergen.com/. About
How many customers does Vivint have?
Vivint boasts over 1.5 million customers in North America. This month, Vivint has seen both good and bad news. On May 3, the company settled a court action with the US Department of Justice and the Federal Trade Commission, accepting a $20 million fine for alleged violations of the Fair Credit Reporting Act.
When is Zymergen's first quarter 2021?
Webcast Information Zymergen will host a conference call to discuss the first quarter 2021 financial results after market close on Monday, May 24, 2021 at 1:30 pm Pacific Time / 4:30 pm Eastern Time. A webcast of the conference call can be accessed at https://investors.zymergen.com/.
Is Zymergen going public?
Zymergen is the first biofacturing company to go public, but its CEO expects it won’t be the last . Zymergen (ticker: ZY) shares rose 21.45% from its offer price on its first day of trading Thursday and raised $500 million with its IPO. Biofacturing, which is distinct from biomanufacturing, refers to the use of biological processes to make chemicals.
How much did Zymergen raise in IPO?
"I love the symbolism that we're going public on Earth Day," says Zymergen's Josh Hoffman. The synthetic biology company raised $500 million in an IPO set to value the company at more than $3 billion.
When will Zymergen report financial results?
EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 202...
What is Zymergen Bio?
Zymergen partners with Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries. Our first innovations include films designed for electronics companies to use in new categories of smart devices, including rollable tablets and naturally derived UV protection. We create new products with a proprietary platform that unlocks the design and manufacturing efficiency of biological processes with technology’s ability to rapidly iterate and control diverse... [Read more...]
U.S. prosecutors charge Trevor Milton, founder of electric carmaker Nikola, with three counts of fraud
Trevor Milton, founder of EV start-up Nikola, was indicted on three counts of criminal fraud by the U.S. Attorney’s Office in Manhattan for allegedly lying about “nearly all aspects of the business,” according to a grand jury indictment unsealed Thursday.
Amazon drops 137 billion in marketcap - a record
Amazon drops 7.5% today after earnings, losing 137.25 billion in one day. This is the biggest marketcap drop in one day. To put in perspective, if markets were flat, amazon alone would contribute 0.3% in sp500, 0.63% in QQQ, 1.65% for consumer disc sector. The drop is enough, in theory, to send 1100 dollars to every us household.
Does anyone else have a moral obligation not to invest in certain stocks?
I would consider myself a very moral person, I invest but I'd still rather money go to the average person than a corporation. Like if a large company i have money in gets slapped with a deserved fine or lawsuit im happy even though I will lose money
Biden Administration Signals It Is Willing To Return To Lockdowns, School Closures If Recommended By CDC
Clip from today's Whitehouse press briefing - https://twitter.com/jasonrantz/status/1420823679177355264
